PHARMACIE CANINO : revenue, balance sheet and financial ratios

PHARMACIE CANINO is a French company founded 8 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in MARSEILLE (13013), this company of category PME shows in 2020 a revenue of 2.9 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-02

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Historique financier - PHARMACIE CANINO (SIREN 831520903)
Kennzahl 2024 2023 2022 2021 2020 2019
Umsatz N/C N/C N/C N/C 2 947 480 € 2 654 075 €
Nettoergebnis 209 454 € 237 342 € 286 907 € 286 014 € 149 763 € 182 432 €
EBITDA N/C N/C N/C N/C 219 757 € 279 365 €
Nettomarge N/C N/C N/C N/C 5.1% 6.9%

Umsatz und Gewinn- und Verlustrechnung

In 2024, PHARMACIE CANINO generates positive net income of 209 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2019-2024: 182 k€ -> 209 k€.

Nettoergebnis (2024) ?
Nettoergebnis
Definition
Bénéfice ou perte après toutes les charges, y compris impôts et éléments exceptionnels.
Formel
Ordentliches Ergebnis + Außerordentliches Ergebnis - Ertragsteuern

209 454 €

Chargement du compte de résultat...

Évolution graphique

Anzeigen :

Aktiva

Chargement des données...

Passiva

Chargement des données...

Solvenz- und Verschuldungskennzahlen

The debt ratio (= Financial debt / Equity x 100) stands at 49%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 56%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Verschuldungsgrad (2024) ?
Verschuldungsgrad
Definition
Misst das Verhältnis von Schulden zu Eigenkapital.
Formel
(Finanzschulden / Eigenkapital) x 100
Interpretation
< 50% : Faible
50-100% : Moderat
> 100% : Hoch

48.851%

Finanzielle Autonomie (2024) ?
Finanzielle Autonomie
Definition
Anteil des Eigenkapitals an der Gesamtfinanzierung.
Formel
(Eigenkapital / Bilanzsumme) x 100
Interpretation
> 30% : Gute Autonomie
20-30% : Durchschnitt
< 20% : Faible

55.691%

Anlagenaltersquote (2024) ?
Anlagenaltersquote
Definition
Misst den Abnutzungsgrad des Sachanlagevermögens.
Formel
Kumulierte Abschreibungen / Bruttoanlagevermögen x 100
Interpretation
< 50% : Neue Anlagen
50-70% : Normale Abnutzung
> 70% : Alternde Anlagen

40.4%

Entwicklung der Solvenzkennzahlen
PHARMACIE CANINO

Positionnement sectoriel

Debt ratio
48.85 2024
2022
2023
2024
Q1: 16.46
Méd: 58.47
Q3: 154.89
Good -14 pts über 3 Jahre

In 2024, the debt ratio of PHARMACIE CANINO (48.85) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.

Financial autonomy
55.69% 2024
2022
2023
2024
Q1: 28.91%
Méd: 49.95%
Q3: 69.47%
Good +18 pts über 3 Jahre

In 2024, the financial autonomy of PHARMACIE CANINO (55.7%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Liquiditätskennzahlen

The liquidity ratio (= Current assets / Current liabilities) stands at 148.96. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquiditätsquote (2024) ?
Liquiditätsquote
Definition
Fähigkeit, kurzfristige Schulden mit dem Umlaufvermögen zu decken.
Formel
Umlaufvermögen / Kurzfristige Verbindlichkeiten
Interpretation
> 1.5 : Sehr gut
1-1.5 : Angemessen
< 1 : Risque de liquidité

148.963

Entwicklung der Liquiditätskennzahlen
PHARMACIE CANINO

Positionnement sectoriel

Liquidity ratio
148.96 2024
2022
2023
2024
Q1: 129.47
Méd: 182.13
Q3: 260.78
Average +11 pts über 3 Jahre

In 2024, the liquidity ratio of PHARMACIE CANINO (148.96) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.

Umlaufvermögensbedarf und Zahlungsfristen

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operatives Working Capital (2024) ?
Operatives Working Capital
Definition
Besoin de financement généré par le cycle d'exploitation (stocks + créances - dettes fournisseurs).
Formel
Stocks + Créances clients - Dettes fournisseurs
Interpretation
Negativ = freigesetzte Liquidität
Positiv = Finanzierungsbedarf

0 €

Kundenforderungen (2024) ?
Kundenforderungen (Tage)
Definition
Durchschnittliche Zahlungsfrist für Kunden.
Formel
(Kundenforderungen / Umsatz inkl. MwSt.) x 360
Interpretation
< 45j : Gut
45-60j : Durchschnitt
> 60j : Lang

0 j

Lieferantenverbindlichkeiten (2024) ?
Lieferantenverbindlichkeiten (Tage)
Definition
Durchschnittliche Zahlungsfrist von Lieferanten.
Formel
(Lieferantenverbindlichkeiten / Einkäufe inkl. MwSt.) x 360
Interpretation
Je länger die Frist, desto besser für die Liquidität

0 j

Lagerumschlag (2024) ?
Lagerumschlag (Tage)
Definition
Durchschnittliche Lagerdauer für Waren oder Materialien.
Formel
(Vorräte / Einkaufskosten) x 360
Interpretation
Je niedriger das Verhältnis, desto schneller der Umschlag

0 j

Entwicklung des Working Capital und der Zahlungsfristen
PHARMACIE CANINO

Positionnement de PHARMACIE CANINO dans son secteur

Vergleich mit der Branche Commerce de détail de produits pharmaceutiques en magasin spécialisé

Bewertungsschätzung

Based on 225 transactions of similar company sales in 2024, the value of PHARMACIE CANINO is estimated at 2 924 132 € (range 2 036 319€ - 4 374 669€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
225 transactions
2036k€ 2924k€ 4374k€
2 924 132 € Range: 2 036 319€ - 4 374 669€
NAF 5 année 2024

Valuation method used

Net Income Multiple
209 454 € × 14.0x = 2 924 133 €
Range: 2 036 320€ - 4 374 670€

Only this financial indicator is available for this company.

Bewertungsentwicklung

How is this estimate calculated?

This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare PHARMACIE CANINO with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about PHARMACIE CANINO

What is the revenue of PHARMACIE CANINO ?

The revenue of PHARMACIE CANINO in 2020 is 2.9 M€.

Is PHARMACIE CANINO profitable?

Yes, PHARMACIE CANINO generated a net profit of 209 k€ in 2024.

Where is the headquarters of PHARMACIE CANINO ?

The headquarters of PHARMACIE CANINO is located in MARSEILLE (13013), in the department Bouches-du-Rhone.

Where to find the tax return of PHARMACIE CANINO ?

The tax return of PHARMACIE CANINO is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does PHARMACIE CANINO operate?

PHARMACIE CANINO operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.